A. Hillary Steinhart

30.0k total citations · 4 hit papers
146 papers, 8.5k citations indexed

About

A. Hillary Steinhart is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, A. Hillary Steinhart has authored 146 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Genetics, 99 papers in Epidemiology and 53 papers in Surgery. Recurrent topics in A. Hillary Steinhart's work include Inflammatory Bowel Disease (120 papers), Microscopic Colitis (94 papers) and Eosinophilic Esophagitis (23 papers). A. Hillary Steinhart is often cited by papers focused on Inflammatory Bowel Disease (120 papers), Microscopic Colitis (94 papers) and Eosinophilic Esophagitis (23 papers). A. Hillary Steinhart collaborates with scholars based in Canada, United States and Israel. A. Hillary Steinhart's co-authors include Anne M. Griffiths, Gordon R. Greenberg, Mark S. Silverberg, Dan Turner, Cynthia H. Seow, Brian G. Feagan, Richard N. Fedorak, Gary Wild, John WD McDonald and E. Jan Irvine and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

A. Hillary Steinhart

141 papers receiving 8.3k citations

Hit Papers

Development, Validation, and Evaluation of a Pediatri... 1995 2026 2005 2015 2007 1995 2005 2000 250 500 750

Peers

A. Hillary Steinhart
A. Hillary Steinhart
Citations per year, relative to A. Hillary Steinhart A. Hillary Steinhart (= 1×) peers Jean–Frédéric Colombel

Countries citing papers authored by A. Hillary Steinhart

Since Specialization
Citations

This map shows the geographic impact of A. Hillary Steinhart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Hillary Steinhart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Hillary Steinhart more than expected).

Fields of papers citing papers by A. Hillary Steinhart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Hillary Steinhart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Hillary Steinhart. The network helps show where A. Hillary Steinhart may publish in the future.

Co-authorship network of co-authors of A. Hillary Steinhart

This figure shows the co-authorship network connecting the top 25 collaborators of A. Hillary Steinhart. A scholar is included among the top collaborators of A. Hillary Steinhart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Hillary Steinhart. A. Hillary Steinhart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lowes, Michelle A., et al.. (2021). Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?. American Journal of Clinical Dermatology. 22(2). 139–147. 11 indexed citations
2.
Charbit‐Henrion, Fabienne, Cécilia Landman, Harry Sokol, et al.. (2016). P583. Real-world use and effectiveness of golimumab for ulcerative colitis in Canada. Journal of Crohn s and Colitis. 10(suppl 1). S396.2–S396. 1 indexed citations
3.
Zittan, Eran, Boyko Kabakchiev, Orlaith Kelly, et al.. (2016). Development of the Harvey-Bradshaw Index-pro (HBI-PRO) Score to Assess Endoscopic Disease Activity in Crohn’s Disease. Journal of Crohn s and Colitis. 11(5). jjw200–jjw200. 31 indexed citations
4.
Nguyen, Geoffrey C., Aliya Gulamhusein, Reka Thanabalan, et al.. (2013). The Utility of Screening for Asymptomatic Lower Extremity Deep Venous Thrombosis during Inflammatory Bowel Disease Flares. Inflammatory Bowel Diseases. 19(5). 1053–1058. 14 indexed citations
5.
Elkadri, Abdul, Joanne M. Stempak, Thomas D. Walters, et al.. (2013). Serum Antibodies Associated with Complex Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 19(7). 1499–1505. 27 indexed citations
6.
Waterman, Matti, Wei Xu, Amreen Dinani, et al.. (2012). Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease. Gut. 62(3). 387–394. 93 indexed citations
7.
Seow, Cynthia H., Eric I. Benchimol, A. Hillary Steinhart, Anne M. Griffiths, & Anthony Otley. (2009). Budesonide for Crohn's disease. Expert Opinion on Drug Metabolism & Toxicology. 5(8). 971–979. 15 indexed citations
8.
Seow, Cynthia H., Alvin Newman, Sue P. Irwin, et al.. (2009). Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis. Gut. 59(1). 49–54. 430 indexed citations
9.
Steinhart, A. Hillary, et al.. (2007). Systematic review: the potential influence of mesalazine formulation on maintenance of remission in Crohn’s disease. Alimentary Pharmacology & Therapeutics. 25(12). 1389–1399. 23 indexed citations
10.
Turner, Dan, Catharine M. Walsh, A. Hillary Steinhart, & Anne M. Griffiths. (2006). Response to Corticosteroids in Severe Ulcerative Colitis: A Systematic Review of the Literature and a Meta-Regression. Clinical Gastroenterology and Hepatology. 5(1). 103–110. 451 indexed citations
11.
Steinhart, A. Hillary, Klaus Ewe, Anne M. Griffiths, R Modigliani, & Ole Østergaard Thomsen. (2003). Corticosteroids for maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews. 2010(1). CD000301–CD000301. 146 indexed citations
12.
Steinhart, A. Hillary, et al.. (2003). Home Total Parenteral Nutrition. Journal of Gastrointestinal Surgery. 7(4). 562–566. 25 indexed citations
13.
Steinhart, A. Hillary, Brian G. Feagan, Cindy J. Wong, et al.. (2002). Combined budesonide and antibiotic therapy for active Crohn's disease: A randomized controlled trial. Gastroenterology. 123(1). 33–40. 157 indexed citations
14.
Toner, Brenda B., Robert Maunder, Gordon R. Greenberg, et al.. (2001). Concerns of patients with inflammatory bowel disease: results from a clinical population. The American Journal of Gastroenterology. 96(6). 1816–1821. 112 indexed citations
15.
Steinhart, A. Hillary, et al.. (2001). Budesonide for maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews. CD002913–CD002913. 21 indexed citations
16.
Rioux, John D., Mark S. Silverberg, Mark J. Daly, et al.. (2000). Genomewide Search in Canadian Families with Inflammatory Bowel Disease Reveals Two Novel Susceptibility Loci. The American Journal of Human Genetics. 66(6). 1863–1870. 383 indexed citations
17.
Sutherland, L. R. & A. Hillary Steinhart. (1998). Mesalazine as a maintenance treatment in Crohn’s disease. Gut. 42(1). 143.3–143.
18.
Steinhart, A. Hillary & Robin S. McLeod. (1996). Medical and surgical management of perianal Crohn's disease. Inflammatory Bowel Diseases. 2(3). 200–210. 4 indexed citations
19.
Steinhart, A. Hillary, Keith O’Rourke, Bruce G. Wolff, & Robin S. McLeod. (1992). Application of a stopping rule based on total treatment failures: The postoperative crohn's disease trial. Journal of Clinical Epidemiology. 45(5). 495–504. 5 indexed citations
20.
Steinhart, A. Hillary, Jeffrey P. Baker, Aaron Brzezinski, & E. J. Prokipchuk. (1990). Azathioprine Therapy in Chronic Ulcerative Colitis. Journal of Clinical Gastroenterology. 12(3). 271–275. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026